Literature DB >> 193050

Catecholamine synthesis in rat brain after axotomy: interaction between apomorphine and haloperidol.

W Kehr, A Carlsson, M Lindqvist.   

Abstract

Axotomy of the ascending monoaminergic fibers by means of a complete cerebral hemitransection stimulated the formation of dopa during 30 min after inhibition of the aromatic amino acid decarboxylase with 3-hydroxybenzylhydrazine HCl, 100 mg/kg i.p., in c. striatum and the dopamine-rich part of the limbic system. Apomorphine, 0.5 mg/kg i.p., antagonized the accumulation of dopa not only on the intact but also on the lesioned side. Haloperidol, 2 mg/kg i.p., stimulated dopa accumulation on the intact side but could not further stimulate the increase in dopa caused by transection. When both drugs were given together, the inhibitory effect of apomorphine was fully counteracted by haloperidol on both sides. In the predominantly noradrenaline-innervated occipito-temporal cortex dopa formation was slightly higher on the lesioned than on the intact side and was not markedly influenced by apomorphine. In the rest of the hemispheres the apomorphine-induced decrease in dopa formation was more pronounced on the intact than on the lesioned side and was fully antagonized by haloperidol. The dopamine concentration was slightly higher in the lesioned c. striatum as compared to the intact side irrespective of the drugs administered. In c. striatum and the limbic system haloperidol caused a decrease in dopamine on the intact side which was not antagonized by additional treatment with apomorphine. Hemitransection caused a decrease in noradrenaline especially in the hemisphere portion. Neither apomorphine nor haloperidol or both drugs in combination changed the latter effect. In general, the tyrosine concentration tended to be higher on the lesioned than on the intact side in all brain structures investigated. The data support the view that a local receptor-mediated feedback mechanism exists which is controlling dopamine synthesis even in the absence of impulse flow.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 193050     DOI: 10.1007/bf00499920

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  29 in total

1.  A fluorometric method for the estimation of tyrosine in plasma and tissues.

Authors:  T P WAALKES; S UDENFRIEND
Journal:  J Lab Clin Med       Date:  1957-11

2.  Cyclic AMP content and regulation of tyrosine-3-mono-oxygenase in rat striatum.

Authors:  B Zivkovic; A Guidotti; E Costa
Journal:  J Cyclic Nucleotide Res       Date:  1976

3.  Early and selective increase in brain dopamine levels after axotomy.

Authors:  N E Andén; P Bédard; K Fuxe; U Ungerstedt
Journal:  Experientia       Date:  1972-03-15

4.  The inhibition of catecholamine biosynthesis by apomorphine.

Authors:  M Goldstein; L S Freedman; T Backstrom
Journal:  J Pharm Pharmacol       Date:  1970-09       Impact factor: 3.765

5.  Evidence for dopamine receptor stimulation by apomorphine.

Authors:  N E Andén; A Rubenson; K Fuxe; T Hökfelt
Journal:  J Pharm Pharmacol       Date:  1967-09       Impact factor: 3.765

6.  Effects of drugs influencing monoamine mechanisms on the increase in brain dopamine produced by axotomy or treatment with gammahydroxybutyric acid.

Authors:  N E Andén; T Magnusson; G Stock
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

7.  The determination of dopamine by a modification of the dihydroxyindole fluorimetric assay.

Authors:  C V Atack
Journal:  Br J Pharmacol       Date:  1973-08       Impact factor: 8.739

8.  Further studies on the accumulation and disappearance of catecholamines formed from tyrosine-14C in mouse brain. Effect of some phenothiazine analogues.

Authors:  H Nybäck; G Sedvall
Journal:  Eur J Pharmacol       Date:  1970-05       Impact factor: 4.432

9.  Distribution of dopamine in the rat cerebral cortex.

Authors:  W Kehr; M Lindqvist; A Carlsson
Journal:  J Neural Transm       Date:  1976       Impact factor: 3.575

10.  A method for the determination of 3,4-dihydroxyphenylalanine (DOPA) in brain.

Authors:  W Kehr; A Carlsson; M Lindqvist
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

View more
  13 in total

1.  Regulatory aspects of nigrostriatal dopaminergic neurons.

Authors:  P Miu; F Karoum; G Toffano; J W Commissiong
Journal:  Exp Brain Res       Date:  1992       Impact factor: 1.972

2.  Effect of lisuride and LSD on monoamine synthesis after axotomy or reserpine treatment in rat brain.

Authors:  W Kehr; W Speckenbach
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978 Jan-Feb       Impact factor: 3.000

3.  Dopamine D2 agonist-induced behavioural depression is reversed by dopamine D1 agonists.

Authors:  D M Jackson; S B Ross; S R Edwards
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575

4.  The 5-HT 1A receptor agonist, 8-OH-DPAT, preferentially activates cell body 5-HT autoreceptors in rat brain in vivo.

Authors:  S Hjorth; T Magnusson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-11       Impact factor: 3.000

5.  Role of dopamine storage function in the control of rat striatal tyrosine hydroxylase activity.

Authors:  B A McMillen; P A Shore
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-08       Impact factor: 3.000

6.  Evidence for an inhibitory presynaptic component of neuroleptic drug action.

Authors:  J S de Belleroche; H F Bradford
Journal:  Br J Pharmacol       Date:  1981-03       Impact factor: 8.739

7.  The activities of monoamine oxidase-A and -B, succinate dehydrogenase and acid phosphatase in the rat brain after hemitransection.

Authors:  A Carlsson; C J Fowler; T Magnusson; L Oreland; A Wiberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-02       Impact factor: 3.000

8.  Influence of dopamine synthesis on methamphetamine-induced changes in striatal and adrenal tyrosine hydroxylase activity.

Authors:  J W Gibb; F J Kogan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-12       Impact factor: 3.000

9.  Dopaminergic and non-dopaminergic neurons in substantia nigra: differential response to bromocriptine.

Authors:  E Scarnati; C Forchetti; G Ciancarelli; C Pacitti; A Agnoli
Journal:  J Neural Transm       Date:  1980       Impact factor: 3.575

10.  Multiple receptors for brain dopamine.

Authors:  M Titeler; P Weinreich; D Sinclair; P Seeman
Journal:  Proc Natl Acad Sci U S A       Date:  1978-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.